Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $476.08 | 6 | 68.4% |
| Food and Beverage | $219.52 | 10 | 31.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $471.36 | 9 | $0 (2024) |
| Indivior Inc. | $78.80 | 1 | $0 (2018) |
| ITI, Inc. | $46.91 | 1 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $46.50 | 2 | $0 (2024) |
| Allergan Inc. | $37.37 | 2 | $0 (2018) |
| Lundbeck LLC | $14.66 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $139.49 | 2 | Teva Pharmaceuticals USA, Inc. ($111.49) |
| 2023 | $93.25 | 2 | Teva Pharmaceuticals USA, Inc. ($74.75) |
| 2021 | $106.90 | 2 | Teva Pharmaceuticals USA, Inc. ($59.99) |
| 2020 | $225.13 | 6 | Teva Pharmaceuticals USA, Inc. ($225.13) |
| 2018 | $111.10 | 3 | Indivior Inc. ($78.80) |
| 2017 | $19.73 | 1 | Allergan Inc. ($19.73) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/07/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $111.49 | General |
| 01/31/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 06/15/2023 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $74.75 | General |
| 02/15/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $18.50 | General |
| Category: PSYCHOLOGY | ||||||
| 08/25/2021 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $59.99 | General |
| 03/02/2021 | ITI, Inc. | CAPLYTA (Drug) | Education | In-kind items and services | $46.91 | General |
| Category: PSYCHIATRY | ||||||
| 12/01/2020 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: Central Nervous System | ||||||
| 11/17/2020 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Central Nervous System | ||||||
| 11/10/2020 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $9.67 | General |
| Category: Central Nervous System | ||||||
| 08/11/2020 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: Central Nervous System | ||||||
| 07/23/2020 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $111.45 | General |
| 06/15/2020 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $71.49 | General |
| 11/01/2018 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $78.80 | General |
| Category: OUD | ||||||
| 04/05/2018 | Lundbeck LLC | TRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $14.66 | General |
| Category: PSYCHIATRY | ||||||
| 03/08/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/25/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 117 | 637 | $114,912 | $44,129 |
| 2022 | 4 | 117 | 694 | $126,200 | $47,369 |
| 2021 | 4 | 139 | 869 | $165,604 | $63,338 |
| 2020 | 4 | 124 | 840 | $162,984 | $56,368 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 156 | $40,560 | $14,760 | 36.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 201 | $35,376 | $12,716 | 35.9% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 19 | 154 | $25,872 | $10,214 | 39.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 36 | 126 | $13,104 | $6,438 | 49.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 174 | $45,240 | $16,089 | 35.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 216 | $38,016 | $13,265 | 34.9% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 17 | 177 | $29,736 | $11,718 | 39.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 33 | 127 | $13,208 | $6,297 | 47.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 269 | $69,856 | $26,008 | 37.2% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 26 | 270 | $45,360 | $18,544 | 40.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 222 | $39,156 | $13,354 | 34.1% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 37 | 108 | $11,232 | $5,432 | 48.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 272 | $70,720 | $21,843 | 30.9% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 27 | 279 | $46,872 | $18,825 | 40.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 213 | $37,488 | $11,438 | 30.5% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 25 | 76 | $7,904 | $4,262 | 53.9% |
About Dr. W Campbell, MD
Dr. W Campbell, MD is a Psychiatry healthcare provider based in Bend, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801844790.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. W Campbell, MD has received a total of $695.60 in payments from pharmaceutical and medical device companies, with $139.49 received in 2024. These payments were reported across 16 transactions from 6 companies. The most common payment nature is "Education" ($476.08).
As a Medicare-enrolled provider, Campbell has provided services to 497 Medicare beneficiaries, totaling 3,040 services with total Medicare billing of $211,203. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Bend, OR
- Active Since 05/04/2006
- Last Updated 01/14/2015
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801844790
Products in Payments
- SUBLOCADE (Drug) $78.80
- CAPLYTA (Drug) $46.91
- AUSTEDO (Drug) $42.19
- AVYCAZ (Drug) $37.37
- Qelbree (Drug) $28.00
- QELBREE (Drug) $18.50
- TRINTELLIX (Drug) $14.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Bend
Donald Anderson, M.d, M.D
Psychiatry — Payments: $805.03
Dr. Anjula Ceesay, Do, DO
Psychiatry — Payments: $635.62
Dr. Gary Levinson, M.d, M.D
Psychiatry — Payments: $627.55
Amit Bhatia, Md, MD
Psychiatry — Payments: $345.22
Joseph Barrett, Md, MD
Psychiatry — Payments: $206.45
Dr. Danielle Hafner, Md, MD
Psychiatry — Payments: $175.00